Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $19 | $19 | $19 | $18 |
| % Growth | -0.6% | 0.3% | 10.1% | – |
| Cost of Goods Sold | $15 | $15 | $15 | $13 |
| Gross Profit | $5 | $5 | $5 | $5 |
| % Margin | 24.6% | 25.3% | 25.2% | 27.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $2 | $0 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $3 | $4 | $3 | $3 |
| Operating Income | $1 | $1 | $2 | $2 |
| % Margin | 7.2% | 7% | 7.8% | 10.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $1 | $1 | $1 | $2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $0 | $1 | $1 |
| % Margin | 2.8% | 2.6% | 3.5% | 5.5% |
| EPS | 0.92 | 0.85 | 0.57 | 0.83 |
| % Growth | 8.2% | 49.1% | -31.3% | – |
| EPS Diluted | 0.92 | 0.85 | 0.57 | 0.83 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | $3 | $3 | $3 | $4 |
| % Margin | 16.6% | 16.5% | 17.6% | 20.1% |